GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings has disclosed Non-Current Deferred Tax Liability across 3 years of filings, most recently posting $650000.0 for Q3 2022.

• In Q3 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $650000.0; the TTM figure through Sep 2022 stood at $650000.0 (changed N/A YoY), while the FY2021 annual figure was $244000.0, changed N/A from the prior year.
• Non-Current Deferred Tax Liability came in at $650000.0 for Q3 2022 at GoodRx Holdings, up from $455000.0 in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q3 2020 to a low of $244000.0 in Q4 2021.
• Average Non-Current Deferred Tax Liability over 3 years is $703600.0, with a median of $455000.0 recorded in 2022.